Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Vandetanib as a potential treatment for breast cancer
HTML
Details
Locations
Year:
2014
Type:
review
Source:
Expert Opinion on Investigational Drugs
DOI:
10.1517/13543784.2014.942034
Authors:
Antonella De Luca,
Amelia D’Alessio,
Monica Rosaria Maiello,
Marianna Gallo,
Simona Bevilacqua,
Daniela Frezzetti,
Alessandro Morabito,
Francesco Perrone,
Nicola Normanno
show all 9
Institution:
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Language:
English
Topic:
Angiogenesis and VEGF in Cancer
Subfield:
Molecular Biology
Field:
Biochemistry, Genetics and Molecular Biology
Domain:
Life Sciences
Keywords:
vandetanib,
breast cancer,
VEGFR2,
tumor angiogenesis,
tyrosine kinase inhibitors,
EGFR,
RET,
metastatic breast cancer,
drug resistance,
anti-angiogenic therapy,
predictive biomarkers,
pharmacokinetics,
pharmacodynamics
show all 13
SDG:
Good health and well-being
Open Access status:
closed
OpenAlex ID:
W2109727303
FWCI:
0.15
Cites:
47
Cited by:
15
Related to:
10